首页> 外国专利> RADIO-LABELLED ANTIBODY FRAGMENTS FOR USE IN THE PROGNOSIS, DIAGNOSIS OF CANCER AS WELL AS FOR THE PREDICTION OF CANCER THERAPY RESPONSE

RADIO-LABELLED ANTIBODY FRAGMENTS FOR USE IN THE PROGNOSIS, DIAGNOSIS OF CANCER AS WELL AS FOR THE PREDICTION OF CANCER THERAPY RESPONSE

机译:放射性标记的抗体片段,用于癌症的预后,诊断以及癌症治疗反应的预测

摘要

The application provides polypeptides comprising or essentially consisting of at least one heavy chain variable domain of a heavy chain antibody (VHH) or a functional fragment thereof, wherein said VHH or a functional fragment thereof specifically binds to a target protein that is present on and/or specific for a solid tumor, e.g. HER2. The application further provides nucleic acids encoding such polypeptides; methods for preparing such polypeptides; host cells expressing or capable of expressing such polypeptides; compositions, and in particular to pharmaceutical compositions, that comprise such polypeptides, nucleic acids and/or host cells. The application further provides such polypeptides, nucleic acids, host cells and/or compositions, for use in methods for detection, imaging, prognosis and diagnosis of cancer as well as for predicting patient response(s) to therapeutics.
机译:本申请提供了包含或基本上由重链抗体的至少一个重链可变域(V HH )或其功能片段组成的多肽,其中所述V HH 或其功能片段特异性结合存在于实体瘤上和/或对实体瘤具有特异性的靶蛋白,例如HER2。本申请进一步提供了编码这样的多肽的核酸。制备此类多肽的方法;表达或能够表达这种多肽的宿主细胞;组合物,特别是药物组合物,其包含此类多肽,核酸和/或宿主细胞。本申请进一步提供了这样的多肽,核酸,宿主细胞和/或组合物,用于癌症的检测,成像,预后和诊断以及预测患者对治疗的反应的方法中。

著录项

  • 公开/公告号US2020276340A1

    专利类型

  • 公开/公告日2020-09-03

    原文格式PDF

  • 申请/专利权人 VRIJE UNIVERSITEIT BRUSSEL;

    申请/专利号US202016827032

  • 申请日2020-03-23

  • 分类号A61K51/10;C07K16/30;C07K16/32;G01N33/574;

  • 国家 US

  • 入库时间 2022-08-21 11:22:15

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号